In the mid-1880s, an Ayurvedic practitioner Dr. S.K. Burman concocted medicines for diseases like cholera and malaria. He went on to set up Dabur India Ltd in 1884 to mass-produce his Ayurvedic formulations. His son, C.L. Burman, set up Dabur's first R&D unit. The current chairman, Dr. Anand Burman, and vice-chairman Amit Burman, are part of the fifth generation of the Burman family. The Burmans were among the first business families in India to separate ownership from management when they handed over the management of the company to professionals in 1998.
Dabur stock price January 7, 2000 to November 27, 2018
Dabur stock price as on January 7, 2000: Rs.24.49/- per share
Dabur stock price as on November 27, 2018: Rs.420.80/- per share
Dabur is one of the India's largest Ayurvedic medicine & natural consumer products manufacturer.
Dabur demerged its Pharma business in 2003 and hived it off into a separate company, Dabur Pharma Ltd. German company Fresenius SE bought a 73.27% equity stake in Dabur Pharma in June 2008 at Rs 76.50 a share.
Dabur's Healthcare Division has over 260 products for treating a range of ailments and body conditions, from common cold to chronic paralysis. Dabur International, a fully owned subsidiary of Dabur India formerly held shares in the UAE based Weikfield International, which it sold in June 2012.
(Source : www.nseindia.com, www.dabur.com, www.wikipedia.com)
DISCLAIMER : THIS BLOG IS FOR INFORMATION AND NOT TO SOLICIT ANY BUSINESS. PAST PERFORMANCE IS NOT AN INDICATION OF THE PERFORMANCE OF STOCK IN FUTURE.
